Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside

Transfusion

Volumn 46, Issue 6, 2006, Pages 896-902

  Cardo, Lisa J ^a   Salata, Jeanne ^b   Harman, Ronald ^b   Mendez, Juan ^b   Weina, Peter J ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD; BLOOD FILTER; ERYTHROCYTE; FILTRATION; HUMAN; HUMAN CELL; LEISHMANIA; LEUKOCYTE; LEUKODEPLETION FILTER; NONHUMAN; NORMAL HUMAN; PROMASTIGOTE; VASCULARIZATION;

ANIMALS; BLOOD TRANSFUSION; ERYTHROCYTES; FILTRATION; HUMANS; LEISHMANIA; LEISHMANIASIS; LEUKOCYTE REDUCTION PROCEDURES;

EID: 33744474036     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00821.x     Document Type: Article

References (29)

1. World Health Organization. Control of Leishmaniases. Expert Committee. World Health Organ Tech Rep Series 1990 793 : 27.
2. Roberts LJ, Handman E, Foote SJ. Science, medicine and the future: Leishmaniasis. BMJ 2000 321 : 801 4.
3. Chung HL, Chow HK, Lu JP. The first two cases of transfusion kala-azar. Chin Med J 1948 66 : 325 6.
4. Andre R, Brumpt L, Dreyfus B, Passelecq A, Jacob S. Cutaneous leishmaniasis, cutaneous glandular leishmaniasis and transfusional kala-azar. Trop Dis Bull 1958 55 : 379 81.
5. Kostmann R, Barr M, Bengtsson E, Garnham PC, Hult G. Kala-azar transferred by exchange blood transfusions in two Swedish infants. Proceedings of the Seventh International Congress of Tropical Medicine and Malaria 1963 Sep 1-11 Rio de Janeiro, Brazil. Vol. 2, p. 384.
6. Cohen C, Corazza F, De Mol P, Brasseur D. Leishmaniasis acquired in Belgium [letter]. Lancet, 1991 338 : 128.
7. Mauny I, Blanchot I, Degeilh B, et al. Visceral leishmaniasis in an infant in Brittany: discussion on the modes of transmission outside of the endemic zone. Pediatrie 1993 48 : 237 9.
8. Cummins D, Amin S, Halil O, et al. Visceral leishmaniasis after cardiac surgery. Arch Dis Child 1995 72 : 235 6.
9. Singh S, Chaudhry VP, Wali J. Transfusion-transmitted kala-azar in India. Transfusion 1996 36 : 848 9.
10. Mathur P, Samantaray JC. The first probable case of platelet-transfusion- transmitted visceral leishmaniasis. Transfus Med 2004 14 : 319 21.
11. Meinecke CK, Schottelius J, Oskam L, Fleisher B. Congenital transmission of visceral Leishmaniasis (Kala Azar) from an asymptomatic mother to her child. Pediatrics 1999 104 : e65.
12. Symmers W. Leishmaniasis acquired by contagion a case of marital infection in Britain. Lancet 1960 : 172 32.
13. Reiner SI, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995 13 : 151 77.
14. Herwaldt BL. Leishmaniasis. Lancet 1999 354 : 1191 9.
15. Grogl M, Daugirda JL, Hoover DL, Magill AJ, Berman J. Survivability and infectivity of viscerotropic Leishmania tropica from Operation Desert Storm participants in human blood products maintained under blood bank conditions. Am J Trop Med Hyg 1993 49 : 308 15.
16. Visconti MR, Pennington J, Garner SF, Allain JP, Williamson LM. Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR. Blood 2004 103 : 1137 9.
17. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995 86 : 3599 603.
18. Hillyer CD, Emmens RK, Zago-Novaretti M, Berkman EM. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion 1994 34 : 929 34.
19. Smith KL, Cobain T, Dunstan RA. Removal of cytomegalovirus DNA from donor blood by filtration. Br J Haematol 1993 83 : 640 2.
20. Kobayashi M, Yano M, Kwon KW, et al. Leukocyte depletion of HTLV-I carrier red cell concentrates by filters. In : Sekiguchi S, editor. Clinical application of leucocyte depletion. Cambridge : Blackwell 1993. p. 1 38 48.
21. Mettille FC, Salata KF, Belanger KJ, Casleton BG, Kelly DJ. Reducing the risk of transfusion-transmitted rickettsial disease by WBC filtration, using Orentia tsutsugamushi in a model system. Transfusion 2000 40 : 290 6.
22. Moraes-Souza H, Borodin JO, Bardossy L, MacPherson DW, Blajchman MA. Prevention of transfusion-associated Chagas disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood. Transfusion 1995 35 : 723 6.
23. Kreutzer RD, Christensen HA. Characterization of leishmania spp. by isoenzyme electrophoresis. Am J Trop Med Hyg 1980 29 : 199 208.
24. le Fichoux Y, Quaranta JF, Aufeuvre JP, et al. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 1999 37 : 1953 7.
25. Souto-Padron T. The surface charge of trypanosomatids. An Acad Bras Cienc 2002 74 : 649 75.
26. Muhlpfordt H. Vergleichende electronenmikrospische untersuchung uber die markierung von Leishmania donovani, Leishmania tropica, und Leishmania braziliensis mit ferritin. Tropenmed Parasitol 1975 26 : 385 9.
27. Pimenta PF, De Souza W. Leishmania mexicana amazonensis: surface charge of amastigote and promastigote forms. Exp Parasitol 1983 56 : 194 206.
28. Ayesta C, Arguello C, Hernandez AG. Leishmania braziliensis: cell surface differences in promastigotes of pathogenic and non pathogenic strains. Exp Parasitol 1985 59 : 185 91.
29. Saraiva EM, Vannier-Santos MA, Silva Filho HC, DeSouza W. Anionic site behavior in leishmania and its role in the parasite-macrophage interaction. J Cell Sci 1989 93 : 481 9.